Cita APA

Bone, H. G., Cosman, F., Miller, P. D., Williams, G. C., Hattersley, G., Hu, M., . . . Saag, K. G. (2018). ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis. J Clin Endocrinol Metab.

Citación estilo Chicago

Bone, Henry G., et al. "ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis." J Clin Endocrinol Metab 2018.

Cita MLA

Bone, Henry G., et al. "ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis." J Clin Endocrinol Metab 2018.